These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 27570154)

  • 1. Bench to bedside in appetite research: Lost in translation?
    Rodgers RJ
    Neurosci Biobehav Rev; 2017 May; 76(Pt A):163-173. PubMed ID: 27570154
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacology of appetite suppression: implication for the treatment of obesity.
    Halford JC
    Curr Drug Targets; 2001 Dec; 2(4):353-70. PubMed ID: 11732637
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Behavioural satiety sequence (BSS): separating wheat from chaff in the behavioural pharmacology of appetite.
    Rodgers RJ; Holch P; Tallett AJ
    Pharmacol Biochem Behav; 2010 Nov; 97(1):3-14. PubMed ID: 20214921
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacological approaches for the treatment of obesity.
    Fernández-López JA; Remesar X; Foz M; Alemany M
    Drugs; 2002; 62(6):915-44. PubMed ID: 11929339
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regulation of appetite to treat obesity.
    Kim GW; Lin JE; Valentino MA; Colon-Gonzalez F; Waldman SA
    Expert Rev Clin Pharmacol; 2011 Mar; 4(2):243-59. PubMed ID: 21666781
    [TBL] [Abstract][Full Text] [Related]  

  • 6. New molecular targets in the pathophysiology of obesity and available treatment options under investigation.
    Valsamakis G; Lois K; Kumar S; Mastorakos G
    Clin Obes; 2014 Aug; 4(4):209-19. PubMed ID: 25826792
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Obesity: Current and potential pharmacotherapeutics and targets.
    Narayanaswami V; Dwoskin LP
    Pharmacol Ther; 2017 Feb; 170():116-147. PubMed ID: 27773782
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Drug strategies for the treatment of obesity.
    Alemany M; Remesar X; Fernández-López JA
    IDrugs; 2003 Jun; 6(6):566-72. PubMed ID: 12811679
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacotherapy of obesity: currently marketed and upcoming agents.
    Bays H; Dujovne C
    Am J Cardiovasc Drugs; 2002; 2(4):245-53. PubMed ID: 14727970
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacological management of appetite expression in obesity.
    Halford JC; Boyland EJ; Blundell JE; Kirkham TC; Harrold JA
    Nat Rev Endocrinol; 2010 May; 6(5):255-69. PubMed ID: 20234354
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The pharmacotherapy of obesity].
    Budai KA; Mirzahosseini A; Noszál Béla ; Tóth G
    Acta Pharm Hung; 2015; 85(1):3-17. PubMed ID: 26137782
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Models and strategies in the development of antiobesity drugs.
    Agahi A; Murphy KG
    Vet Pathol; 2014 May; 51(3):695-706. PubMed ID: 23860008
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel pharmacotherapies for obesity poised to enter market.
    Jones D
    Nat Rev Drug Discov; 2009 Nov; 8(11):833-4. PubMed ID: 19876031
    [No Abstract]   [Full Text] [Related]  

  • 14. Pharmacotherapy of obesity: emerging drugs and targets.
    Chakrabarti R
    Expert Opin Ther Targets; 2009 Feb; 13(2):195-207. PubMed ID: 19236237
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Pharmacological therapy of obesity].
    Pagotto U; Vanuzzo D; Vicennati V; Pasquali R
    G Ital Cardiol (Rome); 2008 Apr; 9(4 Suppl 1):83S-93S. PubMed ID: 18773755
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of tesofensine on appetite sensations.
    Gilbert JA; Gasteyger C; Raben A; Meier DH; Astrup A; Sjödin A
    Obesity (Silver Spring); 2012 Mar; 20(3):553-61. PubMed ID: 21720440
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Drug treatment of obesity: established and emerging therapies.
    Isidro ML; Cordido F
    Mini Rev Med Chem; 2009 Jun; 9(6):664-73. PubMed ID: 19519492
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacological review of Caralluma R.Br. with special reference to appetite suppression and anti-obesity.
    Dutt HC; Singh S; Avula B; Khan IA; Bedi YS
    J Med Food; 2012 Feb; 15(2):108-19. PubMed ID: 22191633
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serotonergic drugs : effects on appetite expression and use for the treatment of obesity.
    Halford JC; Harrold JA; Boyland EJ; Lawton CL; Blundell JE
    Drugs; 2007; 67(1):27-55. PubMed ID: 17209663
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Limitations in anti-obesity drug development: the critical role of hunger-promoting neurons.
    Dietrich MO; Horvath TL
    Nat Rev Drug Discov; 2012 Sep; 11(9):675-91. PubMed ID: 22858652
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.